Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol Imaging in CNS Inflammation
NCT00659776Phase 2Terminated
- Sponsor
- Oregon Health & Science University
- Start
- Jul 2004
- Primary completion
- Dec 2020
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferumoxytol in central nervous system inflammation, cerebrovascular disease, lymphadenopathy, sponsored by Oregon Health & Science University. Started Jul 2004; status: terminated.
02
Drugs
ferumoxytol
03
Conditions
central nervous system inflammationcerebrovascular diseaselymphadenopathy
Beyond the preview
Go deeper on NCT00659776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659776.